Leru Polliana Mihaela
Clinical Department 5, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Internal Medicine, Colentina Clinical Hospital/Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Cureus. 2022 Feb 13;14(2):e22177. doi: 10.7759/cureus.22177. eCollection 2022 Feb.
Mast cells are granulocytic immunomodulatory cells with an important role in physiologic and pathogenic processes due to their location at the junction between the internal and external environment and to their capacity to release a broad range of active mediators. Mast cells mediators have both pro-inflammatory and anti-inflammatory activities and are implicated in various and complex pathology. Mast cells disorders (MCDs) represent a heterogeneous pathology, with frequently difficult and challenging evaluation and diagnostic workup. MCDs can be primary, secondary to other diseases, or idiopathic. Increased research interest in this field was noted during the last decade and various classification criteria, as well as diagnostic and treatment recommendations, were proposed. The aim of this paper is to review the most recent published data on the classification and evaluation of mast cells disorders and to point out the main difficulties in diagnosing and managing these complex diseases in medical practice.
肥大细胞是粒细胞性免疫调节细胞,因其位于内外部环境的交界处且具有释放多种活性介质的能力,在生理和致病过程中发挥着重要作用。肥大细胞介质具有促炎和抗炎活性,并与各种复杂的病理状况相关。肥大细胞疾病(MCDs)是一种异质性病理状态,其评估和诊断检查常常困难且具有挑战性。MCDs可以是原发性的、继发于其他疾病或特发性的。在过去十年中,该领域的研究兴趣有所增加,并提出了各种分类标准以及诊断和治疗建议。本文的目的是回顾关于肥大细胞疾病分类和评估的最新发表数据,并指出在医疗实践中诊断和管理这些复杂疾病的主要困难。